Stereotaxis Inc (STXS) Stock Price, Quote & News

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed t...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 314 678 6100

Website: www.stereotaxis.com

Address:

710 North Tucker Boulevard, Suite 110, Saint Louis, United States

Georges8792 Apr. 24 at 3:27 PM

$STXS i sold 2 block of 50k shares each. First took a little bit time, second went super fast

1 · Reply

Eddypgil Apr. 24 at 2:06 PM

$STXS still don’t understand how Stxs buys robocath and pays all those new salaried engineers. Maybe David sees some GenesisX sales

1 · Reply

Ratman44 Apr. 23 at 3:45 PM

$STXS for those that may not have found this… https://www.linkedin.com/posts/marienhaus-gruppe_kardiologie-marienhaus-marienhausgruppe-activity-7449457639060643840-cY1S?utm_medium=ios_app&rcm=ACoAAAEPyhEB79dMOJESYKxHjUGqHBJaC0yodc0&utm_source=social_share_send&utm_campaign=copy_link

1 · Reply

Eddypgil Apr. 23 at 1:50 PM

$STXS if company had a reliable source of magic catheters the price would be much higher.

1 · Reply

Ratman44 Apr. 22 at 2:08 PM

$STXS the importance here is the arm access. If they continue with arm access this is a paradigm shift in how procedures are done. This is a gigantic advantage. https://www.linkedin.com/posts/stereotaxis_magic-chd-activity-7452704398746472448-VhCS?utm_medium=ios_app&rcm=ACoAAAEPyhEB79dMOJESYKxHjUGqHBJaC0yodc0&utm_source=social_share_send&utm_campaign=copy_link

2 · Reply

trigger_finger Apr. 21 at 5:13 PM

$STXS No "official launch" announcement of Genesis X at HRS 2026. Not a good look David. You have been talking about doing a official launch at HRS since 2024 Q3 conference call. System and Magic been available in Europe since early 2025. You are the ultimate over promise/under deliver CEO. You can not be believed at all. pathetic. 1.39 next here unfortunately(imo) https://x.com/Stereotaxis/status/2046635575399092705?s=20

1 · Reply

jacksonjohn750 Apr. 20 at 6:42 PM

$STXS do the offering already....

1 · Reply

Daquanladariusblackman3 Apr. 20 at 3:56 PM

$STXS YIIIKKKEEESSS

0 · Reply

alexpitti Apr. 18 at 9:29 PM

$STXS

0 · Reply

Georges8792 Apr. 18 at 4:49 AM

$STXS https://www.linkedin.com/posts/marc-craig_endovascular-stereotaxis-robocath-ugcPost-7450474603899994112-rlf1?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via

1 · Reply

Stereotaxis Announces First MAGiC Procedures in the United States

Apr 21, 2026, 9:01 AM EDT - 4 days ago

Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026

Apr 15, 2026, 7:00 AM EDT - 10 days ago

Stereotaxis Announces Definitive Agreement to Acquire Robocath

Apr 6, 2026, 8:06 AM EDT - 19 days ago

Stereotaxis Announces FDA Clearance and Launch of Synchrony System

Mar 9, 2026, 4:01 PM EDT - 6 weeks ago

Stereotaxis Reports 2025 Full Year Financial Results

Feb 12, 2026, 9:00 AM EST - 2 months ago

Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026

Feb 9, 2026, 8:06 AM EST - 2 months ago

Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program

Jan 6, 2026, 8:01 AM EST - 3 months ago

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

Nov 24, 2025, 8:58 AM EST - 5 months ago

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

Nov 11, 2025, 4:01 PM EST - 5 months ago

Stereotaxis Reports 2025 Third Quarter Financial Results

Nov 10, 2025, 4:05 PM EST - 5 months ago

GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance

Oct 21, 2025, 9:00 AM EDT - 6 months ago

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

Oct 15, 2025, 7:32 AM EDT - 6 months ago

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

Oct 13, 2025, 7:34 AM EDT - 6 months ago

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

Sep 22, 2025, 7:56 AM EDT - 7 months ago

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System

Sep 2, 2025, 8:08 AM EDT - 8 months ago

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

Sep 2, 2025, 7:51 AM EDT - 8 months ago

Stereotaxis to Present at Upcoming Investor Conferences

Aug 28, 2025, 7:47 AM EDT - 8 months ago

Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025

Aug 7, 2025, 4:01 PM EDT - 9 months ago

Stereotaxis Reports 2025 Second Quarter Financial Results

Jul 28, 2025, 7:48 AM EDT - 9 months ago

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

Jul 23, 2025, 8:00 AM EDT - 9 months ago

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 17, 2025, 8:32 AM EDT - 10 months ago

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

Jul 1, 2025, 9:00 AM EDT - 10 months ago

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

May 12, 2025, 4:01 PM EDT - 1 year ago

Stereotaxis Reports 2025 First Quarter Financial Results

Apr 22, 2025, 7:00 AM EDT - 1 year ago

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Apr 21, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Mar 19, 2025, 8:01 AM EDT - 1 year ago

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

Mar 10, 2025, 8:02 AM EDT - 1 year ago

Stereotaxis to Present at 37th Annual Roth Conference

Mar 3, 2025, 7:32 AM EST - 1 year ago

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

Mar 3, 2025, 7:31 AM EST - 1 year ago

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

Mar 3, 2025, 7:30 AM EST - 1 year ago

Stereotaxis Reports 2024 Full Year Financial Results

Feb 25, 2025, 8:03 AM EST - 1 year ago

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

Feb 3, 2025, 4:05 PM EST - 1 year ago

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Jan 30, 2025, 8:09 AM EST - 1 year ago

Stereotaxis Announces First GenesisX Robotic System Order

Jan 27, 2025, 8:00 AM EST - 1 year ago

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Jan 14, 2025, 7:21 AM EST - 1 year ago

Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology

Dec 9, 2024, 7:25 AM EST - 1 year ago

Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA

Dec 2, 2024, 8:45 AM EST - 1 year ago

Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems

Nov 26, 2024, 8:28 AM EST - 1 year ago

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 25, 2024, 8:21 AM EST - 1 year ago

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

Nov 20, 2024, 8:18 AM EST - 1 year ago

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

Nov 11, 2024, 4:02 PM EST - 1 year ago

Stereotaxis Reports 2024 Third Quarter Financial Results

Oct 21, 2024, 8:41 AM EDT - 1 year ago

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

Sep 3, 2024, 8:53 AM EDT - 1 year ago

Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Stereotaxis Reports 2024 Second Quarter Financial Results

Aug 12, 2024, 4:03 PM EDT - 1 year ago

Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX

Jul 22, 2024, 4:05 PM EDT - 1 year ago

Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024

Jul 18, 2024, 4:13 PM EDT - 1 year ago

Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir

May 29, 2024, 8:25 AM EDT - 2 years ago

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

May 24, 2024, 8:37 AM EDT - 2 years ago

Stereotaxis Receives CE Mark Recertification Under EU's MDR Regulatory Framework

Georges8792 Apr. 24 at 3:27 PM

$STXS i sold 2 block of 50k shares each. First took a little bit time, second went super fast

1 · Reply

Eddypgil Apr. 24 at 2:06 PM

$STXS still don’t understand how Stxs buys robocath and pays all those new salaried engineers. Maybe David sees some GenesisX sales

1 · Reply

Ratman44 Apr. 23 at 3:45 PM

1 · Reply

Eddypgil Apr. 23 at 1:50 PM

$STXS if company had a reliable source of magic catheters the price would be much higher.

1 · Reply

Ratman44 Apr. 22 at 2:08 PM

2 · Reply

trigger_finger Apr. 21 at 5:13 PM

1 · Reply

jacksonjohn750 Apr. 20 at 6:42 PM

$STXS do the offering already....

1 · Reply

Daquanladariusblackman3 Apr. 20 at 3:56 PM

$STXS YIIIKKKEEESSS

0 · Reply

alexpitti Apr. 18 at 9:29 PM

$STXS

0 · Reply

Georges8792 Apr. 18 at 4:49 AM

1 · Reply

Georges8792 Apr. 17 at 2:03 PM

$STXS hope you will make an impact 500 … 5000 …. 50000 https://www.linkedin.com/posts/arnold-vetterli_coo-medtech-operationalexcellence-share-7450605558883213312-E0fd?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via

3 · Reply

jb06000 Apr. 17 at 11:23 AM

$STXS https://medtechdaily.beehiiv.com/p/the-magnetic-takeover-the-living-heart

0 · Reply

Georges8792 Apr. 17 at 10:28 AM

$STXS https://www.linkedin.com/posts/veronica-sawyer-b-s-m-p-t-9ba14ba5_prostatecancer-medtech-urology-share-7450793409914605568-P5w2?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via

1 · Reply

Daquanladariusblackman3 Apr. 16 at 3:11 PM

$MBOT I would say the same thing about $STXS but there is no strength 🤷🏽‍♂️

1 · Reply

zbenz Apr. 16 at 2:23 PM

$STXS all great theories in theory , i just care about getting hardware into the field and making a profit aka "execution" ... this looks like another R&D initiative with additions to it's ecosystem way down the road , the funding aspects are important, but they gotta deliver...I've basically buried this in my "black hole" portfolio category and have extended my time line to hold another 5 years and if it becomes a MX bagger i'd almost say i got lucky, thats reality folks , just my practical opinion

4 · Reply

jb06000 Apr. 16 at 10:56 AM

$STXS By completing this deal, Stereotaxis isn't just buying a company; they are buying an "entry ticket" to these specific funds: Sovereign European Funding: As a U.S. company, STXS couldn't easily access Horizon Europe (the €14 Billion health fund). Now, through Robocath's French headquarters, they can. The Robocath "Subsidiary" Advantage: STXS can keep Robocath as a French entity to continue receiving Bpifrance support, which is often reserved for companies with significant R&D operations on French soil.

0 · Reply

jb06000 Apr. 16 at 10:55 AM

$STXS The Robocath deal essentially gives Stereotaxis a "dual-passport" for funding. They can chase ARPA-H dollars in the US and Horizon Europe/EIC euros in France simultaneously. Robocath has a very active history of securing European and French government grants, which is likely one of the reasons the acquisition is so strategic for Stereotaxis. They have consistently "tapped in" to public money to fund their R&D. In their major funding rounds (like the €40 million Series C in 2020), a significant portion of the support structure involved government-backed innovation loans and regional development grants from the Normandy region.

1 · Reply

Georges8792 Apr. 16 at 3:09 AM

$STXS well i think microport saved our ass by giving us access to their catheters in europe so screw up David had to return the favor …

2 · Reply

Ratman44 Apr. 16 at 12:22 AM

$STXS for those that didn’t put it together the P/E firm that was formerly behind Robocath was Mivroport. We never received a name of who was the partner that invested in STXS. I have a feeling that was also Microport. Microport is STXS Chinese partner and they may have saved STXS with their catheter approvals in Europe.

3 · Reply

Ratman44 Apr. 15 at 5:37 PM

$STXS so has anyone connected the dots yet?

2 · Reply

zbenz Apr. 15 at 3:52 PM

$STXS Tony , probably and realistically dead money for next 12 months until they get their show me story in place and speculators will bid it up , at this point, it's still a biz plan on paper

0 · Reply

BioTuesdays Apr. 15 at 2:46 PM

$STXS has announced that it has entered into a definitive agreement to acquire closely held Robocath, a venture-backed innovator of robotic techniques for interventional cardiology and neurointerventions, based in France. https://biotuesdays.com/2026/04/15/stereotaxis-to-acquire-robocath/

0 · Reply

Market Cap	191.06M
Revenue (ttm)	32.38M
Net Income (ttm)	-21.64M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-66.83%
Debt to Equity Ratio	0.00

Volume	528,200
Avg Vol	444,848
Day's Range	N/A - N/A
Shares Out	97.48M
Stochastic %K	30%
Beta	1.43
Analysts	Strong Sell
Price Target	$4.20